The hepatic steatosis index (HSI) was lower after SGLT2i treatment but did not reach statistical significance.
← all excerpts
Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis.
1
—
—